Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans: Effects of antifungal agents

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 1, 1996, Pages 67-73

  Hawser, Stephen ^a   Islam, Khalid ^a  

^a Gruppo Lepetit SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; CANDIDA ALBICANS; DRUG EFFECT; GENETIC TRANSFORMATION; GENETICS; METHODOLOGY; MORPHOGENESIS; SPECTROPHOTOMETRY; TIME; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; MORPHOGENESIS; SPECTROPHOTOMETRY; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS; TRANSFORMATION, GENETIC;

EID: 0030179437     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.1.67     Document Type: Article

References (13)

1. Barchiesi, F., Del Poeta, M., Morbiducci, V., Ancarani, F. & Scalise, G. (1993). Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans. Mycopathologia 124, 19-25.
2. Emori, T. G. & Gaynes, R. P. (1993). An overview of nosocomial infections, including the role of the microbiology laboratory. Clinical Microbiology Reviews 6, 428-42.
3. Galgiani, J. N. (1993). Susceptibility testing of fungi: current status of the standardization process. Antimicrobial Agents and Chemotherapy 37, 2517-21.
4. Gaskin, F., Cantor, C. R. & Shelanski, M.L. (1974). Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules. Journal of Molecular Biology 89, 737-58.
5. Hawser, S. P. & Douglas, L. J. (1994). Biofilm formation by Candida species on the surface of catheter materials in vitro. Infection and Immunity 62, 915-21.
6. Jansen, T., Borgers, M., van de Ven, M.-A., Zhonneux, B., Wouters, L., van Gerven, F. et al. (1991). The effects of saperconazole on the morphology of Candida albicans, Pityrosporum ovale and Trichophyton rubrum in vitro. Journal of Medical and Veterinary Mycology 29, 293-303.
7. National Committee for Clinical Laboratory Standards. (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Proposed Standard: M27-P. NCCLS, Villanova, PA.
8. Odds, F. C. (1988). Candida and Candidosis, 2nd edn. Balliere Tindall, London.
9. Odds, F. C. (1992). Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. Antimicrobial Agents and Chemotherapy 36, 1727-37.
10. Pfaller, M. A. & Barry, A. L. (1994). Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 32, 1992-6.
11. Strippoli, V., Simonetti, N., Villa, A. & Bruzzese, T. (1992). Antimicrobial activity of SPA-S-753, a new erivative of partricin A. European Bulletin of Drug Research 1, 113-8.
12. van Cutsem, J., van Gerven, F. & Janssen, P. A. J. (1986). The in vitro evaluation of azoles. In In Vitro and In Vivo Evaluation of Antifungal Agents (Iwata K. & Vanden Bossche, H., Eds), pp. 51-64. Elsevier Science Publishers, Amsterdam.
13. Vanden Bossche, H. (1995). Chemotherapy of human fungal infections. In Modern Selective Fungicides. Properties, Applications, Mechanism of Action (Lyr, H., Ed.). Gustav Fisher Verlag, Jena.